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A new modification of the oligonucleotide-mediated mutagenesis technique has been developed. The pro- 
posed methodology has been used to produce specific base changes in the double-stranded plasmid DNA. 
For this purpose, special cloning vectors have been constructed using the synthetic oligodeoxyribonucleo- 
tides. The developed method allows the production of mutant DNA from those of the wild-type with a 
yield of lo-207;. 
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1. INTRODUCTION 
Nowadays, site-directed mutagenesis of genes is 
successfully applied for studying structure-func- 
tion relations in corresponding proteins [ 11. Muta- 
tions in structural genes allow the production of 
proteins with specific amino acid changes that in 
some cases might result in obtaining modified 
molecules with increased or novel biological ac- 
tivities [2-41. Moreover, the directed mutagenesis 
together with the data on primary and spatial pro- 
tein structure provides information on the role of 
particular amino acids in the functioning of pro- 
tein active sites, assembling of its subunits, etc., 
thus providing a method to study the mechanism 
of protein action. 
Mutational changes in known DNA sequence 
can be effected in a number of ways [1,5], but the 
most precise way to introduce specific mutations in 
cloned DNA fragments is through the use of syn- 
thetic oligodeoxyribonucleotides as site-specific 
mutagens [6]. The general strategy of oligonucleo- 
tide-directed mutagenesis involves an application 
of synthetic oligonucleotide carrying the desired 
mutation (point substitution of the heterocyclic 
base, deletion or insertion) as a primer to direct the 
DNA synthesis on a single-stranded circular DNA 
template. So, the oligonucleotide is incorporated 
into the second DNA strand. After ligation, trans- 
formation of this closed circular heteroduplex 
DNA into E. co/i cells followed by in vivo DNA 
replication resolves this heteroduplex into mutant 
and original, wild-type gene. The mutant can be 
easily identified against a background of nonmu- 
tant DNAs by hybridization with the same oligo- 
nucleotide [5-71. 
To carry out oligonucleotide-directed mutagen- 
esis, two systems are generally employed: single- 
stranded DNA phages (such as bacteriophage Ml 3 
and its derivatives, or dXl74) or single-stranded 
circular plasmid DNAs. The latter are produced 
from the supercoiled double-stranded plasmid 
DNA by introducing nick(s) into one of the 
plasmid chains under the action of some restriction 
endonucleases in the presence of ethidium bromide 
(or by DNase I) with the following digestion of the 
nicked strand with exonuclease [2,8]. However, in 
this case the yields of mutants are low (on average, 
from 0.01 to 1%). The application of single- 
stranded DNA phages is more effective (the yields 
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are 2-5070) but this approach has also a number of 
disadvantages, in particular, long duration of the 
experiment and necessity of special treatment for 
enrichment of the material with mutant DNA. 
Moreover, in both cases application of DNA 
polymerase for the primer elongation on the exten- 
sive, completely single-stranded circular template 
leads to appearance of false mutations. Decreasing 
the yield of the desired mutation also occurs, ow- 
ing to the presence in the reaction mixture of many 
DNA molecules with an incompletely repaired se- 
cond strand, since DNA polymerase has difficul- 
ties in passing over template regions with secon- 
dary structure, in particular origin of replication 
f9,lOl. 
In order to increase the yield of mutation and 
simplify the general methodology, we have de- 
signed a modified procedure for changing specific 
nucleotides in a DNA sequence with high efficien- 
cy. The method is based on the application of a 
linear double”stranded plasmid DNA with a single- 
stranded sequence in the region for mutagenesis. 
2. MATERIALS AND METHODS 
Restriction endonucleases, E. cdi exonuclease 
III, E. cofi DNA polymerase I (Klenow fragment) 
and deoxynucleoside triphosphates were obtained 
from P-L Biochemicals. [Y-~‘P]ATP (- 5000 
Ci/mmol) was from Amersham. T4 polynucleotide 
kinase, T4 DNA ligase and T4 DNA polymerase 
were isolated as described 11 i]_ The oiigodeox- 
yribonucleotides were synthesized by the rapid N- 
methylimidazoiide phosphotriester method 1121. 
To prepare circular heteroduplex DNA, recom- 
binant plasmid (2 pg) was treated with H’aI in 20 
~1 of 20 mM Tris-HCl (pH 7.5)/l mM dithio- 
threitol/50 mM NaClI6 mM MgClt, or Smat in the 
same volume of 20 mM KCl/lO mM Tris-HCl (pH 
8.0)/6 mM MgCWi mM dithiothreitol, for 1 h. 
Then 6-8 units of exonuclease III (or 10 units of T4 
DNA polymerase) were added. The reaction mix- 
ture was incubated at 25°C for 2-10 min. The reac- 
tion was stopped by heating to 60°C and the solu- 
tion was extracted twice with phenol and then once 
with diethyl ether. The DNA was precipitated by 
adding 0.2 vol of 1 M sodium acetate and 2 vols 
ethanol. After centrifugation, the pellet was 
washed with ethanol, dried and dissolved in 50.~1 
of 50 mM Tris-HCl (pH 7.9)/10 mM MgCl~/20 
mM NaCl. The synthetic oligonucleotide (40-200 
pmol) was added. Then the mixture was heated to 
SO-55°C for 5 min and allowed to cool slowly to 
room temperature. The four deoxynucleoside 
triphosphates were added to yield a final concen- 
tration of 300 PM, ATP to 100 ,uM and DTT to 1 
mM. After the addition of E. coli DNA poly- 
merase I (Klenow fragment) (30 units) and T4 
DNA ligase (10 units), the reaction mixture was in- 
cubated for 5-6 h at 20°C. 
4-5 ~1 of this mixture was used directly to 
transform competent E. co/i HBlOl cells. Compe- 
tent cells were prepared and transformations were 
done according to (131. A second cycle of transfor- 
mation was usually done after a quick pIasmid 
preparation [ 141. Colony screening and hybridiza- 
tion with 32P-labeled oligonucleotide were done as 
described earlier [ 151. 
To determine the exact time of exonuclease 
digestion, a linear form of recombinant plasmid 
(1Opg) was treated with exonuclease III (40 units) 
at 25”C, or with T4 DNA polymerase (50 units) at 
37”C, in 150 ~1 of 20 mM Tris-WC1 (pH 7.5)/10 
mM MgCl2/50 mM NaCl/l mM dithiothreitol. 
Aliquots (30~1) were taken each 2-5 min, and 1 M 
sodium acetate (pH 4.5) (2.&), 1 M NaCl(5&, 0.1 
M ZnCl2 (2 ,&), Hz0 (10 ~1) and 1 ~1 (4 units) of 
Sr nuclease (Sigma) were added to each sample. 
After incubation at 20°C for 15 min, the reaction 
was stopped by the addition of EDTA. To deter- 
mine the size of the double-stranded DNA ob- 
tained after the removal of the single-stranded 
regions by Sr nuclease, the samples were subjected 
to 1.5% agarose gel electrophoresis. The starting 
linear plasmid DNA and the Hind111 digest of 
lambda DNA were used as DNA length markers. 
3. RESULTS AND DISCUSSION 
The proposed modified procedure involves using 
specially constructed cloning vectors pBRS1, pHS1 
and pHS2. These plasmids are derivatives of 
pBR322 in which the EcoRI-Hind111 region has 
been replaced by synthetic duplexes carrying Seal, 
Hpd and X/z01 sites. Schemes for production of 
the plasmids are shown in fig.t. The substitution 
of the EcoRI-Hind111 region in plasmid pBR322 
for the synthetic duplex consisting of oligonucleo- 
tides d(AATTCCCCGGG) (I) and d(AGCTTCC- 
CGGGG) (II) led to pBRS1 which had the SmaI 
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Fig.1. Scheme for construclion of recombinant plasmids 
pBRS1, pHS1 and pHS2. Relevant restriction sites are 
indicated. 
site. Then, insertion of the double-stranded frag- 
ment consisted of 15mers d(AATTGTTAACTC- 
GAG) (III) and d(AATTCTCGAGTTAAC) (IV) 
into the EcoRI site of pBRS1 resulted in the forma- 
tion of the piasmids pHSf and pHS2 containing 
the unique HpaI and EcoRI sites. These vectors 
differ only in orientation of the 15-bp insertion, 
and they are obtained simultaneously by inserting 
this synthetic duplex into pBRS1. After the trans- 
formation of E. coli cells with this mixture, they 
were separated on the level of plasmid DNAs 
isolated from the colonies chosen by hybridization 
with 32P-labeIed oligonucieotide (III). Then they 
were identified by the restriction analysis and the 
direct determination of the primary structure of 
the EcoRI-Hind111 fragment. 
According to a procedure developed by us, the 
DNA fragment to be mutagenized is cIoned in the 
vectors pBRS I, pHS 1 and pHS2 using any suitable 
restriction site located in the EcoRI-BarnHI region 
situated close to SmaI, HpaI and EcoRV sites of 
these plasmids. The recombinant plasmid obtained 
is digested with one of these enzymes to produce 
double-stranded DNA with blunt ends. This linear 
DNA is a substrate for E. cuii exonuclease III (or 
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Fig.2. Overall scheme for oligonucleotide-directed mutagenesis of double-stranded linear plasmid DNA. 
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T4 DNA polymerase). The digestion in controlled 
conditions produces duplex with protruding single- 
stranded 5’-ends which include the site of the pro- 
posed mutation. Degradation of the DNA outside 
this region, where the sequence alters, occurs to a 
minimal degree (fig.2). 
Limited degradation of DNA under the ex- 
onuclease action is achieved by using the con- 
trolled amounts of the exonuclease added to the 
reaction mixture and by the fixed time of its ac- 
tion. Usually, the incubation of DNA at 25°C for 
5 min with 3-4 units of E. coli exonuclease III per 
1 pg DNA leads to cleavage of about 300-400 
residues from the 3’-ends of the duplex chains. T4 
DNA polymerase works slower and cleaves off the 
same number of residues for 20 min. The exact 
time of exonuclease treatment should be deter- 
mined empirically as described in section 2. 
The next step includes annealing the synthetic 
oligonucleotide, which contains the desired muta- 
tion, with the plasmid DNA prepared as described 
above and the following completion of single- 
stranded regions of the molecule by the action of 
E. coli DNA polymerase I (Klenow fragment) in 
the presence of T4 DNA ligase. The latter provides 
the closing of the obtained heteroduplex into the 
cyclic molecule. 
The obtained heteroduplex DNA is used to 
transform E. co/i cells. Usually, about several 
thousand colonies grown for 16-18 h of incubation 
on LB-medium containing 1% agar and ampicillin 
(25 pg/ml). Several hundred (more often 200) 
clones are screened by hybridization with the same 
32P-labeled oligonucleotide-mutagen as a highly 
specific probe. Hybridization is carried out as 
described [15]. The temperature of the hybridiza- 
tion will vary with the sequence and length of the 
oligonucleotide and the type of mutation. As a 
rule, mutant colonies identified by colony hybrid- 
ization after the first transformation with hetero- 
duplex DNA contain a mixture of wild-type and 
mutant plasmids. For their separation a second 
transformation of E. coli with plasmid preparation 
isolated from these ‘mixed’ colonies is necessary. 
As shown in fig.3, a second screening allows iden- 
tification of ‘pure’ mutant colonies which usually 
compose from 40 to 60% of all the secondary ob- 
tained colonies. 
The experiments carried out showed that under 
the applied conditions the yields of mutant cloned 
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Fig.3. Autoradiograms showing the result of a colony 
screen by hybridization in situ with a “P-labeled 18-base 
oligonucleotide to select mutants of the gene for human 
proinsulin. (A) Screening after a first transformation of 
E. coli, plasmid DNA isolated from colony shown by an 
arrow was used for second transformation; (B) screening 
after a second transformation, the darkest colonies 
proved to be the desired mutants. 
after the first transformation of bacteria by hetero- 
duplex DNA are up to lo-20% of the total amount 
of colonies. Thus, partial removal of one of the 
strands in plasmid DNA which affects mainly 
region of the desired mutation considerably de- 
creases the possibility of formation of unplanned, 
‘false’ mutations at other sites of the plasmid. 
Besides, it facilitates the mission of DNA poly- 
merase and does not affect the origin of replication 
of the vector molecule. 
The procedure described above was used to in- 
troduce mutations into the gene for human proin- 
sulin [16], promoter G2 of bacteriophage fd DNA 
[17] and other cloned synthetic DNAs. Autoradio- 
grams obtained at determination of the sequence 
of human proinsulin gene region before and after 
insertion of mutation are presented in fig.4. 
It must be noted that this technique can be ex- 
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Fig.4. Maxam-Gilbert sequence analysis gel showing the 
part of the synthetic gene for human proinsulin contain- 
ing a mutation (A) and the initial gene (B). 
tended to any DNA sequence which has a unique 
site of restriction endonuclease generating blunt 
ends. It can be also applied to replicative form of 
phage DNAs (e.g., derivatives of Ml3 phage 
DNA: M13mp8, M13mp9, M13mp12, etc.) having 
polylinker sequences suitable for cloning and 
unique sites of blunt-ended restriction enzymes. 
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